Besides, in studies on adriamycin resistance in ovarian cancer, UA has been linked to the HuR/MDR1 axis, where it not only mitigates resistance but also enhances the sensitivity of ovarian cancer (SK-OV-3 and A2780) cells to adriamycin [1048]. Here, ELAVL1 is linked to ovarian carcinoma.